Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Galimedix Therapeutics, |
Description | Galimedix is an ophthalmic pharmaceutical company developing truly novel and transformative treatments for several neurodegenerative |
Keywords | N/A |
WebSite | galimedix.com |
Host IP | 54.208.101.55 |
Location | United States |
Site | Rank |
US$356,627
Last updated: 2023-05-06 23:03:02
galimedix.com has Semrush global rank of 29,678,939. galimedix.com has an estimated worth of US$ 356,627, based on its estimated Ads revenue. galimedix.com receives approximately 41,150 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, galimedix.com is safe to visit. |
Purchase/Sale Value | US$356,627 |
Daily Ads Revenue | US$330 |
Monthly Ads Revenue | US$9,876 |
Yearly Ads Revenue | US$118,510 |
Daily Unique Visitors | 2,744 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
galimedix.com. | A | 1799 | IP: 54.208.101.55 |
galimedix.com. | A | 1799 | IP: 174.129.30.187 |
galimedix.com. | NS | 1800 | NS Record: dns2.registrar-servers.com. |
galimedix.com. | NS | 1800 | NS Record: dns1.registrar-servers.com. |
galimedix.com. | MX | 3600 | MX Record: 0 galimedix-com.mail.protection.outlook.com. |
galimedix.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
galimedix.com. | TXT | 1800 | TXT Record: MS=ms89315815 |
Home About Overview Strategy Management Team Board of Directors Products Technology Overview MOA Preclinical Experiments Glaucoma Preclinical Data AMD Preclinical Data Trigger Effect Superior Approach Neurorestoration Clinical Trials References News & Media Press Releases Presentations Posters Events In the News Videos Contact Treating the Leading Causes of Blindness and Alzheimer’s disease Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease. About Us A Potentially Disruptive Technology Galimedix Therapeutics is developing two unique small molecules GAL-101 and GAL-201 specifically to block a key underlying step in neurodegeneration: formation of toxic oligomers of amyloid beta (Aβ). These toxic Aβ oligomers have emerged as the central cause |
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 22:05:25 GMT Server: Apache Location: http://www.galimedix.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Content-Type: text/html; charset=UTF-8 Date: Tue, 26 Oct 2021 22:05:25 GMT Expires: Thu, 19 Nov 1981 08:52:00 GMT Location: https://www.galimedix.com/ Pragma: no-cache Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Tue, 26 Oct 2021 22:05:25 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Content-Type: text/html; charset=UTF-8 |
Domain Name: GALIMEDIX.COM Registry Domain ID: 2235079176_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2020-01-28T08:05:56Z Creation Date: 2018-03-04T07:28:14Z Registry Expiry Date: 2022-03-04T07:28:14Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T21:16:26Z <<< |